Literature DB >> 15602758

A novel insertion in the FGFR2 gene in a patient with Crouzon phenotype and sacrococcygeal tail.

Pablo Lapunzina1, Alejandra Fernández, Juan M Sánchez Romero, Alicia Delicado, Miguel Sáenz de Pipaon, Isidora López Pajares, Jesús Molano.   

Abstract

BACKGROUND: Mutations in the FGFR2 gene are present in several syndromes with craniosynostosis, such as Pfeiffer's, Apert's, and Crouzon's. CASE: We report a case of craniosynostosis (Crouzon phenotype) with tracheal anomalies and a sacrococcygeal tail. In addition, the patient shows dolichoplagiocephaly, prominent occiput, proptosis, mild facial asymmetry, strabismus, small umbilical hernia, and syndactyly of the second and third toes.
CONCLUSIONS: Molecular analysis of the FGFR2 gene in this patient revealed a 12-bp insertion (GAGGAGACCTAG) at nucleotide 824. This is an in-frame mutation that adds four amino acid residues to the immunoglobulin IIIa (IgIIIa) domain of the putative protein. This is the first report of an in-frame insertion in exon 8 of FGFR2 in a child with Crouzon's syndrome, tracheal anomalies, and a tail.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15602758     DOI: 10.1002/bdra.20093

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  7 in total

Review 1.  Syndromic craniosynostosis, fibroblast growth factor receptor 2 (FGFR2) mutations, and sacrococcygeal eversion presenting as human tails.

Authors:  C Corbett Wilkinson; David K Manchester; Robert F Keating; Lawrence L Ketch; Ken R Winston
Journal:  Childs Nerv Syst       Date:  2012-06-04       Impact factor: 1.475

2.  FGFR2 mutation in a Chinese family with unusual Crouzon syndrome.

Authors:  Zi-Li Li; Xue Chen; Wen-Juan Zhuang; Wei Zhao; Ya-Ni Liu; Fang-Xia Zhang; Ruo-Shui Ha; Jin-Hua Wu; Chen Zhao; Xun-Lun Sheng
Journal:  Int J Ophthalmol       Date:  2016-10-18       Impact factor: 1.779

Review 3.  Craniosynostosis as a clinical and diagnostic problem: molecular pathology and genetic counseling.

Authors:  Anna Kutkowska-Kaźmierczak; Monika Gos; Ewa Obersztyn
Journal:  J Appl Genet       Date:  2018-02-01       Impact factor: 3.240

4.  FGFR2 molecular analysis and related clinical findings in one Chinese family with Crouzon syndrome.

Authors:  Ying Lin; Xuanwei Liang; Siming Ai; Chuan Chen; Xialin Liu; Lixia Luo; Shaobi Ye; Baoxin Li; Yizhi Liu; Huasheng Yang
Journal:  Mol Vis       Date:  2012-02-12       Impact factor: 2.367

5.  Fibroblast growth factor (FGF) signaling in development and skeletal diseases.

Authors:  Chad M Teven; Evan M Farina; Jane Rivas; Russell R Reid
Journal:  Genes Dis       Date:  2014-12-01

6.  Molecular analysis of FGFR 2 and associated clinical observations in two Chinese families with Crouzon syndrome.

Authors:  Ying Lin; Hongbin Gao; Siming Ai; Jacob V P Eswarakumar; Tao Li; Bingqian Liu; Hongye Jiang; Yuhua Liu; Xialin Liu; Yonghao Li; Yao Ni; Jiangna Chen; Zhuoling Lin; Xiaoling Liang; Chenjin Jin; Xinhua Huang; Lin Lu; Yizhi Liu
Journal:  Mol Med Rep       Date:  2016-07-11       Impact factor: 2.952

7.  Detection of G338R FGFR2 mutation in a Vietnamese patient with Crouzon syndrome.

Authors:  Anh Lan Thi Luong; Thuong Thi Ho; Ha Hoang; Trung Quang Nguyen; Tu Cam Ho; Phan Duc Tran; Thuy Thi Hoang; Nam Trung Nguyen; Hoang Ha Chu
Journal:  Biomed Rep       Date:  2019-01-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.